Published trade mark details for 2567572

This information was published on 2025-07-17T02:42:06 for IP Right Filed Published.

Field	Value
(210)	2567572 (IR 1864190)
(220)	30 May 2025
(300)	US, 31 Jan 2025, 99025787
(500)	The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow and are positioned above the word CRENESSITY. The color(s) purple, orange, and yellow is/are claimed as a feature of the mark. The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow and are positioned above the word CRENESSITY.
(511) (510)	Class 5 Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions. Class 42 Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results. Class 44 Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders.
(540)
(550)	Figurative
(730)	Neurocrine Biosciences, Inc.

 

Find out more about publications on the About page.